Suk Mei Wang
Overview
Explore the profile of Suk Mei Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang S, Ooi L, Hui K
Clin Cancer Res
. 2011 Aug;
17(18):6040-51.
PMID: 21825042
Purpose: To assess the significance of Rac GTPase-activating protein 1 (RACGAP1) expression in identifying HBV-positive human hepatocellular carcinoma (HCC) patients who are at high risk for recurrent disease. Experimental Design:...
2.
Tan M, Kumarasinghe M, Wang S, Ooi L, Aw S, Hui K
Exp Biol Med (Maywood)
. 2009 Mar;
234(6):693-702.
PMID: 19307463
Hepatocellular carcinoma (HCC) commonly develops in patients with underlying chronic liver disease. Additionally, the tumorous lesions of HCC patients are consistently characterized by the lack of iron accumulation even when...
3.
Wang S, Ooi L, Hui K
Clin Cancer Res
. 2007 Nov;
13(21):6275-83.
PMID: 17975138
Purpose: To improve the clinical management of human hepatocellular carcinoma (HCC) by accurate identification, at diagnosis, of patients at risk of recurrence after primary treatment for HCC. Experimental Design: Two...
4.
Lam P, Lim K, Wang S, Hui K
Mol Ther
. 2005 Jun;
12(1):144-52.
PMID: 15963930
Glial cell invasion is a multistep cellular process that involves a complex system of tightly regulated proteases (matrix metalloproteinases; MMPs) and their endogenous inhibitors (tissue inhibitors of metalloproteinases; TIMPs) to...
5.
Leo J, Wang S, Guo C, Aw S, Zhao Y, Li J, et al.
Int J Cancer
. 2005 Jun;
117(4):561-8.
PMID: 15945099
Absence of estrogen receptor (ER) and progesterone receptor (PR) is the hallmark of most hormone-independent breast cancers. Previous studies demonstrated that reactivation of PR expression in hormone-independent MDA-MB-231 breast cancer...
6.
Linn Y, Wang S, Hui K
Exp Hematol
. 2005 May;
33(6):671-81.
PMID: 15911091
Objectives: To study the molecular cytolytic mechanism of CD3+CD56+ cytokine-induced killer (CIK) effector cells, especially with reference to their ability to deliver potent cytolytic activities against acute myeloid leukemic (AML),...